Timothy Keutzer Spero Therapeutics, Inc. (SPRO) insider trading activity

Timothy Keutzer is Chief Operating Officer of Spero Therapeutics, Inc.. Currently has a direct ownership of 531,837 shares of SPRO, which is worth approximately $632,886. The most recent transaction as insider was on Aug 27, 2024, when has been sold 2,213 shares (Common Stock) at a price of $1.35 per share, resulting in proceeds of $2,987. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 532K

0.41% 3M change

63.5% 12M change

Total Value Held $632,886

Timothy Keutzer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 27 2024	SELL Open market or private sale	$2,987 $1.35 p/Share	2,213 Reduced 0.41%	531,837 Common Stock
Feb 02 2024	SELL Open market or private sale	$42,120 $1.36 p/Share	30,971 Reduced 5.48%	534,050 Common Stock
Feb 01 2024	BUY Grant, award, or other acquisition	-	239,731 Added 29.79%	565,021 Common Stock
Aug 28 2023	SELL Open market or private sale	$2,336 $1.26 p/Share	1,854 Reduced 0.57%	325,290 Common Stock
Feb 02 2023	SELL Open market or private sale	$6,312 $1.86 p/Share	3,394 Reduced 1.03%	327,144 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	265,957 Added 44.59%	330,538 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	-	38,014 Added 37.05%	64,581 Common Stock
Aug 26 2021	BUY Grant, award, or other acquisition	-	24,067 Added 47.53%	26,567 Common Stock

Timothy Keutzer

Chief Operating Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SPRO shares.

Notify only if

Value

Insider Trading

Get notified when an Spero Therapeutics, Inc. insider buys or sells SPRO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Spero Therapeutics, Inc.

Track Activities on SPRO

Account